Freiburg Myeloma Workshop

Dear Colleagues,

following the practice of assembling outstanding experts at Freiburg University annually, to let them share their insights on advances in multiple myeloma (MM), we are very happy to welcome you all to the 16th MM Meeting 2025. Over the last years, remarkable advances in the field have steadily improved the outcome of patients suffering from plasma cell dyscrasias. Myeloma physicians, both in the clinic and outpatient office, face challenges as the options available add up to a whole variety of valuable treatment strategies.

"16th MM Meeting 2025 – Immune therapies in MM: Moving forward" is the title of our 2025 workshop meeting, which is a live Hybrid meeting again.

We have invited worldwide eminent authorities from the US, Austria and Germany, who will - with UKF experts plus commentary guests - share their data with us in straightforward discussion rounds.

Therewith, we will cover new treatment modalities in MM, will solve, where the future in MM evolves to, what are current, worldwide trials from the US and Europe and pending solutions needed for this disease.

Cordially looking forward to seeing you during this meeting in November 2025

 

Flash talk session | 15 - 17h

Chairs: Prof. Dr. Maria Krauth, Vienna, Dr. Michael Rassner, PD Dr. Christine Greil, Jan Kus, Dr. Henning Schäfer, UKF

Preclinical projects

1. Kirstyn Crossley | Oncostatin M as a key regulator of CD38 expression and a potential biomarker in MM

2. Michael Rassner | Personalized medicine approaches within molecular TB CCCF

3. Niloufar Mohammadkhani, Andreas Frodl, Tanja Hartmann | Bone microenvironment in MM

4. Nina Schlosser, Derya Steenbuck / Oliver Schilling | Proteomics study in healthy volunteers, multiple myeloma and amyloidosis pts: significant differences and ways for better diagnostics?

5. Jakob Neubauer | Structured radiology: Body Composition projects

Clinical projects

6. Hanna Löffler, Magdalena Braun, Heike Reinhardt | Vision of Draining the Data Swamp of ChemoCompile – Opportunities and Challenges in the Development of an Analysis Tool

7. Marie Böttger | CAR-T-cell outcome Ide-cel and Cilta-cel

8. Pauline Sauerborn | Choosing the right immunotherapy: does the use of the R-MCI influence the use of ADC, BITEs and CAR-T-cells?

9. Sina Wenger | Dental study on ONJ avoidance

10. Marius Niewald | AL-Amyloidosis screening via fat-pad biopsy and -aspiration and implication for therapy, including CAR-T cells

11. Carlotta Pietsch, Georg Herget | Do CRAB criteria predict the progression of myeloma bone disease in follow-up patients?

12. Patrick Marschner | Clinical trial update Iomedico: MM

13. Antonia Egert, Marcel Knüttel, Julian Rapp, Max Schinke, Dominik Marschner, Stephan de Bra | Index MM pts with rare MM and/or therapy-induced phenomenons: intracerebral EM MM and bilateral facial palsy after CAR-T-cells with in each review of the literature

Pause: snacks and drinks

The Myeloma Workshop 2025 is an hybrid live event. Participation is possible on site and online and is free of charge.

Online registration for on-site attendance will open soon. 

And if you have any questions, do not hesitate to contact us.

Organizing committee

Medical Center University of Freiburg
Department of Medicine I - Specialties: Hematology, Oncology and Stem Cell Transplantation

Hugstetter Straße 55 I 79106 Freiburg

Prof. Dr. Monika Engelhardt
Mandy-Deborah Möller
Prof. Dr. Ralph Wäsch
Sina Wenger
Stephanie Lavielle

AG Engelhardt
Sektion Klinische Forschung & ECTU MED1

CCCF
Prof. Justus Duyster, Prof. Christoph Peters and CCCF Team

Internet:
www.uniklinik-freiburg.de /medizin1
www.uniklinik.freiburg.de/cccf

Congress Organizer

Medical Center University of Freiburg
Communication Department | Event Management
Elke Bührer

Breisacher Str. 153
79110 Freiburg

+49 761 270-19210

veranstaltung@uniklinik-freiburg.de